Examining the Impact of Connected Devices on GLP-1 Therapy
In a March 2024 survey, Withings Health Solutions asked their database of device users about their experience with GLP-1 treatments and the biomarkers they’ve been monitoring throughout their health journey, garnering responses from 2352 participants.